Aus coViki
Wechseln zu: Navigation, Suche


  • GET 2020. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS) Extract
  • GET ä. Dapsone and Doxycycline could be potential treatment modalities for COVID-19 Extract
  • GET 2020. Dapsone as treatment adjunct in ARDS Extract


  • GET 2020. A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2. Extract


  • GET 2020. Aminosalicylates and COVID-19: Facts or Coincidences? Extract
  • GET 2020. Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections. Extract

Thiopurines azathioprin

  • GET 2020. COVID-19 and implications for thiopurine use. Extract

MMF mycophenolic acid

  • GET 2020. Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2. Extract

mTOR ihibitors rapamycin

  • GET 2020. Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review) Extract
  • GET 2020. The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment Extract
  • GET 2020. Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines. Extract
  • GET 2020. Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia. Extract
  • GET 2020. Obesity and COVID-19: The mTOR pathway as a possible culprit. Extract
  • GET 2020. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19. Extract
  • GET 2020. An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? Extract

Calcineurin inhibitors

  • GET 2020. Calcineurin inhibitors revisited: A new paradigm for COVID-19? Extract

Cyclophilin A inhibitors

  • GET 2020. Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors Extract


GET 2020. Inhibition of SARS-CoV-2 infection by the cyclophilin inhibitor Alisporivir (Debio 025) Extract
  • GET 2020. SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir. Extract

Cyclosporin A

  • GET ä. Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia Extract
  • GET 2020. Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? Extract
  • GET 2020. Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19). Extract
Meine Werkzeuge